# Transcode Therapeutics, Inc.: Form 8-K, filed Jun 13, 2025

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: 8-K
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 20:15 ET
- Period: 2025-06-12
- Accession: 0001104659-25-059362
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/tm2517990d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/

## Items reported

- Item 5.08: Item not in the standard list

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/tm2517990d1_8k.htm

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-059362. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.